<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tailored therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tailored-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 06:12:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tailored therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Antibiotic therapy for infective endocarditis: POET II trial backs shorter, tailored treatment</title>
		<link>https://bioengineer.org/antibiotic-therapy-for-infective-endocarditis-poet-ii-trial-backs-shorter-tailored-treatment/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 06:12:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Duration]]></category>
		<category><![CDATA[endocarditis]]></category>
		<category><![CDATA[infectious diseases]]></category>
		<category><![CDATA[infective]]></category>
		<category><![CDATA[infective endocarditis]]></category>
		<category><![CDATA[POET II trial]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[tailored therapy]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=424916</guid>

					<description><![CDATA[A new randomized trial suggests stopping antibiotics once patients with infective endocarditis are clinically stable can safely shorten treatment, though relapse rates rise and careful patient selection remains essential.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">424916</post-id>	</item>
	</channel>
</rss>
